iBio, Inc. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: iBio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q3 2024.
iBio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.11M, a 19.5% increase year-over-year.
iBio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$15.6M, a 41.7% increase year-over-year.
iBio, Inc. annual Operating Income (Loss) for 2024 was -$16.6M, a 43.3% increase from 2023.
iBio, Inc. annual Operating Income (Loss) for 2023 was -$29.3M, a 1.19% increase from 2022.
iBio, Inc. annual Operating Income (Loss) for 2022 was -$29.7M, a 4.55% increase from 2021.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$15.6M	-$4.11M	+$997K	+19.5%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	-$16.6M	-$3.41M	+$1.56M	+31.3%	Apr 1, 2024	Jun 30, 2024	10-K/A	2024-09-24
Q1 2024	-$18.2M	-$3.63M	+$2.54M	+41.2%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	-$20.7M	-$4.5M	+$6.08M	+57.5%	Oct 1, 2023	Dec 31, 2023	10-Q	2024-02-09
Q3 2023	-$26.8M	-$5.1M	+$2.53M	+33.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-12
Q2 2023	-$29.3M	-$4.97M	+$5.49M	+52.5%	Apr 1, 2023	Jun 30, 2023	10-K/A	2024-09-24
Q1 2023	-$34.8M	-$6.17M	+$619K	+9.12%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-13
Q4 2022	-$35.5M	-$10.6M	-$3.34M	-46.2%	Oct 1, 2022	Dec 31, 2022	10-Q	2024-02-09
Q3 2022	-$32.1M	-$7.64M	-$2.41M	-46.1%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q2 2022	-$29.7M	-$10.5M	-$1.01M	-10.7%	Apr 1, 2022	Jun 30, 2022	10-K	2023-09-27
Q1 2022	-$28.7M	-$6.79M	+$415K	+5.76%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$29.1M	-$7.23M	+$314K	+4.16%	Oct 1, 2021	Dec 31, 2021	10-Q/A	2023-05-19
Q3 2021	-$29.4M	-$5.23M	+$1.7M	+24.5%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$31.1M	-$9.44M	-$6.51M	-222%	Apr 1, 2021	Jun 30, 2021	10-K	2022-10-11
Q1 2021	-$24.6M	-$7.2M	-$3.14M	-77.2%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	-$21.5M	-$7.55M	-$4.39M	-139%	Oct 1, 2020	Dec 31, 2020	10-Q	2022-02-14
Q3 2020	-$17.1M	-$6.92M	-$3.07M	-79.6%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020	-$14M	-$2.93M	+$1.12M	+27.7%	Apr 1, 2020	Jun 30, 2020	10-K	2021-09-28
Q1 2020	-$15.1M	-$4.06M	-$294K	-7.8%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-17
Q4 2019	-$14.8M	-$3.16M	+$860K	+21.4%	Oct 1, 2019	Dec 31, 2019	10-Q	2021-02-16
Q3 2019	-$15.7M	-$3.86M	+$95K	+2.41%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-16
Q2 2019	-$15.8M	-$4.05M	-$107K	-2.71%	Apr 1, 2019	Jun 30, 2019	10-K	2020-10-13
Q1 2019	-$15.7M	-$3.77M	-$277K	-7.93%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-15
Q4 2018	-$15.4M	-$4.02M	-$588K	-17.2%	Oct 1, 2018	Dec 31, 2018	10-Q	2020-02-14
Q3 2018	-$14.8M	-$3.95M	-$589K	-17.5%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-14
Q2 2018	-$14.2M	-$3.95M	-$87K	-2.25%	Apr 1, 2018	Jun 30, 2018	10-K	2019-08-26
Q1 2018	-$14.1M	-$3.49M	+$443K	+11.3%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q4 2017	-$14.6M	-$3.43M	-$102K	-3.07%	Oct 1, 2017	Dec 31, 2017	10-Q	2019-02-13
Q3 2017	-$14.5M	-$3.36M	-$207K	-6.56%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-13
Q2 2017	-$14.3M	-$3.86M	-$1.11M	-40.1%	Apr 1, 2017	Jun 30, 2017	10-K	2018-09-18
Q1 2017	-$13.2M	-$3.94M	-$864K	-28.1%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-11
Q4 2016	-$12.3M	-$3.33M	-$1.07M	-47.5%	Oct 1, 2016	Dec 31, 2016	10-Q	2018-02-14
Q3 2016	-$11.2M	-$3.15M	-$1.34M	-74%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-09
Q2 2016	-$9.89M	-$2.75M	-$858K	-45.3%	Apr 1, 2016	Jun 30, 2016	10-K	2017-09-15
Q1 2016	-$9.04M	-$3.07M	-$1.38M	-82%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-15
Q4 2015	-$7.65M	-$2.25M	-$588K	-35.3%	Oct 1, 2015	Dec 31, 2015	10-Q	2017-02-21
Q3 2015	-$7.06M	-$1.81M	-$397K	-28%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-18
Q2 2015	-$6.67M	-$1.9M	-$746K	-64.9%	Apr 1, 2015	Jun 30, 2015	10-K	2016-10-13
Q1 2015	-$5.92M	-$1.69M	-$394K	-30.4%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-23
Q4 2014	-$5.53M	-$1.67M	-$30K	-1.83%	Oct 1, 2014	Dec 31, 2014	10-Q	2016-02-22
Q3 2014	-$5.5M	-$1.42M	-$1.66M	-690%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-13
Q2 2014	-$3.84M	-$1.15M	+$152K	+11.7%	Apr 1, 2014	Jun 30, 2014	10-K	2015-10-13
Q1 2014	-$3.99M	-$1.29M	+$566K	+30.4%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-15
Q4 2013	-$4.56M	-$1.64M	+$59K	+3.48%	Oct 1, 2013	Dec 31, 2013	10-Q/A	2015-02-24
Q3 2013	-$4.62M	$240K	+$2.05M		Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-14
Q2 2013	-$6.67M	-$1.3M	+$845K	+39.3%	Apr 1, 2013	Jun 30, 2013	10-K	2014-09-29
Q1 2013	-$7.51M	-$1.86M	+$322K	+14.8%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-15
Q4 2012	-$7.83M	-$1.7M	+$979K	+36.6%	Oct 1, 2012	Dec 31, 2012	10-Q	2014-02-14
Q3 2012	-$8.81M	-$1.81M	+$515K	+22.2%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-14
Q2 2012	-$9.33M	-$2.15M	+$1.38M	+39.2%	Apr 1, 2012	Jun 30, 2012	10-K/A	2013-10-04
Q1 2012	-$10.7M	-$2.18M	+$707K	+24.5%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-20
Q4 2011	-$11.4M	-$2.67M	-$808K	-43.3%	Oct 1, 2011	Dec 31, 2011	10-Q	2013-02-19
Q3 2011	-$10.6M	-$2.33M	-$954K	-69.6%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-14
Q2 2011	-$9.65M	-$3.53M			Apr 1, 2011	Jun 30, 2011	10-K/A	2012-10-15
Q1 2011		-$2.89M			Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-15
Q4 2010		-$1.87M			Oct 1, 2010	Dec 31, 2010	10-Q	2012-02-14
Q3 2010		-$1.37M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.